Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 14, 2020; 26(30): 4501-4522
Published online Aug 14, 2020. doi: 10.3748/wjg.v26.i30.4501
Figure 4
Figure 4 Percentage of hepatitis B virus surface antigen and hepatitis B e antigen clearance. Percentage of hepatitis B virus surface antigen and hepatitis B e antigen clearance among patients stratified by baseline, week 24 and week 36 hepatitis B e antigen and hepatitis B virus surface antigen levels; week 36 hepatitis B e antigen change from baseline; weeks 24 and 36 hepatitis B virus surface antigen change from baseline; and week 24 alanine aminotransferase elevation. HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen; ALT: Alanine aminotransferase.

  • Citation: Xing YF, Wei CS, Zhou TR, Huang DP, Zhong WC, Chen B, Jin H, Hu XY, Yang ZY, He Q, Jiang KP, Jiang JM, Hu ZB, Deng X, Yang F, Li FY, Zhao G, Wang LC, Mi YQ, Gong ZJ, Guo P, Wu JH, Shi WQ, Yang HZ, Zhou DQ, Tong GD. Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients. World J Gastroenterol 2020; 26(30): 4501-4522
  • URL: https://www.wjgnet.com/1007-9327/full/v26/i30/4501.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v26.i30.4501